RAC 0.93% $1.62 race oncology ltd

Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-69

  1. 5,612 Posts.
    lightbulb Created with Sketch. 1280
    That was my understanding till I was shown what biotech stocks get bought out for,
    the triangle report shows $5 billion of you divided that by shares on issues
    (163 mill) you get just over $30 but what the triangle report does not show is that generally big pharma will add 3 to 5 times peak sale so if we go in the middle that will be 4 times 5 billion = 20 bill divided by shares on issue 163m you get
    Just over $122 a share and I know that sounds insane but even Dr T said the triangle report was very very conservative.
    So if we get to positive phase 3 then it's top end that's why I'll take triangles report offer for lesser trials
    Last edited by Hunterr: 04/09/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.